budipine
Sign in to saveBudipine (brand name Parkinsan) is an antiparkinson agent marketed for the treatment of Parkinson's disease.
Research
73 papers- Budipine in Parkinson's tremor.Journal of the neurological sciences · 2006
- Clinical efficacy of budipine in Parkinson's disease.Journal of neural transmission. Supplementum · 1999
- Multiple mechanisms of action: the pharmacological profile of budipine.Journal of neural transmission. Supplementum · 1999
- Budipine provides additional benefit in patients with Parkinson disease receiving a stable optimum dopaminergic drug regimen.Archives of neurology · 2002
- Non-dopaminergic therapy in Parkinson's disease.Journal of neurology · 2000
via PubMed
Wikidata facts
- Mass
- 293.214
Show 3 more facts
- Commons category
- Budipine
- chemical formula
- C₂₁H₂₇N
- canonical SMILES
- CC(C)(C)N1CCC(CC1)(C2=CC=CC=C2)C3=CC=CC=C3
via Wikidata · CC0
~1 min read
Article
3 sectionsContents
- Synthesis
- See also
- References
Budipine (brand name Parkinsan) is an antiparkinson agent marketed for the treatment of Parkinson's disease.
While its exact mechanism of action is not well characterized, it is believed to be an NMDA receptor antagonist, but also promoting the synthesis of dopamine.
Available in 11 languages
via Wikidata sitelinks · CC0
Connections
valproic acid
Entity
(RS)-baclofen
Entity
dextropropoxyphene
Entity
pentamidine
Entity
voltage-gated sodium channel
Entity
1-aminocyclopropanecarboxylic acid
Entity
conotoxin
Entity
voltage-gated calcium channel complex
Entity
racemorphan
Entity
cromakalim
Entity
tiapamil
Entity
DL-methorphan
Entity
lanicemine
Entity
rapastinel
Entity
selfotel
Entity
PCPr
Entity
hydrogen
Entity
zinc
Entity
magnesium
Entity
International Standard Book Number
Entity